Dr. Michael Donahue Decker, MD Internal Medicine - Infectious Disease Medicare: Not Enrolled in Medicare Practice Location: 12500 Cookeville Boatdock Rd, Baxter, TN 38544 Phone: 931-239-3663 Fax: 908-927-8674 |
News Archive
Research published in the New England Journal of Medicine suggests that pre-hospital advanced life support training does not increase the survival rate for people who experience a cardiac arrest outside of a hospital. On the other hand, bystander CardioPulmonary Resuscitation and rapid defibrillation programs are crucial interventions that can significantly impact survival rates.
The U.S. Food and Drug Administration recently approved an application that permits B. Braun Medical Inc. (B. Braun) to deliver FDA-approved 1g and 2g Cefepime for Injection USP and Dextrose Injection USP in B. Braun's DUPLEX® Drug Delivery System.
Immune Pharmaceuticals Inc., a clinical stage biopharmaceutical company that engages in the development and commercialization of targeted therapeutics for the treatment of inflammatory diseases and cancer, today completed the underwriter's exercise of partial over-allotment option of 459,697 units, at a price of $2.50 per unit, for gross proceeds of approximately $1.06 million, bringing the aggregate gross proceeds of the Company's previously announced underwritten public offering to $9.685 million.
Researchers have created two tiny instruments capable of detecting a range of contaminants, from molecules to whole bacteria, in food and water, according to an article in the August issue of Microbiology Today.
Oxford Gene Technology (OGT), The Molecular Genetics Company, has entered into a deal with Baylor Miraca Genetics Laboratories (BMGL), licensing the use of OGT's proprietary single nucleotide polymorphism (SNP) array probe technology.
› Verified 8 days ago